Ocular Suspension and Nanosuspension Products: Formulation Development Considerations-Reference-Cited by-同舟云学术

Ocular Suspension and Nanosuspension Products: Formulation Development Considerations

Published:2021 Issue: Volume: Page:317-347
ISSN:2210-7371
Container-title:Ophthalmic Product Development
language:
Short-container-title:

Author:

Agrahari Vivek,Singh Onkar N.

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-030-76367-1_12

Reference39 articles.

1. Abrego G, Alvarado HL, Egea MA, Gonzalez-Mira E, Calpena AC, Garcia ML. Design of nanosuspensions and freeze-dried PLGA nanoparticles as a novel approach for ophthalmic delivery of pranoprofen. J Pharm Sci. 2014;103(10):3153–64. https://doi.org/10.1002/jps.24101.

2. Agrahari V, Agrahari V, Mandal A, Pal D, Mitra AK. How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches. Expert Opin Drug Deliv. 2017;14(10):1145–62. https://doi.org/10.1080/17425247.2017.1272569.

3. Ahmed I, Patton TF. Importance of the noncorneal absorption route in topical ophthalmic drug delivery. Invest Ophthalmol Vis Sci. 1985;26(4):584–7.

4. Ahmed I, Francoeur ML, Thombre AG, Patton TF. The kinetics of timolol in the rabbit lens: implications for ocular drug delivery. Pharm Res. 1989;6(9):772–8.

5. Alexander KS, Azizi J, Dollimore D, Uppala V. Interpretation of the hindered settling of calcium carbonate suspensions in terms of permeability. J Pharm Sci. 1990;79(5):401–6. https://doi.org/10.1002/jps.2600790508.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statistically developed stable Camptothecin-loaded Soluplus/TPGS mixed micelles for improved ovarian cancer treatment;Journal of Dispersion Science and Technology;2024-02-12